Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 13.72
+0.06 (0.44%)
At close: Jan 30, 2026
Guerbet Revenue
Guerbet had revenue of 394.72M EUR in the half year ending June 30, 2025, with 3.93% growth. This brings the company's revenue in the last twelve months to 820.92M, down -2.36% year-over-year. In the year 2024, Guerbet had annual revenue of 851.12M with 6.97% growth.
Revenue (ttm)
820.92M
Revenue Growth
-2.36%
P/S Ratio
0.21
Revenue / Employee
288.85K
Employees
2,905
Market Cap
172.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 851.12M | 55.46M | 6.97% |
| Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
| Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
| Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
| Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eurobio Scientific Société anonyme | 162.47M |
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Implanet | 11.10M |
| Mauna Kea Technologies | 8.18M |
| Affluent Medical | 5.27M |